Levormeloxifene
Levormeloxifene (L-Centchroman) is a selective estrogen receptor modulator (SERM), which prevents and ameliorates postmenopausal osteoporosis. Levormeloxifene causes multiple adverse gynecological effects[1].
Product Specifications
CAS Number
78994-23-7
Product Name Alternative
L-Centchroman; L-Ormeloxifene
UNSPSC
12352005
Target
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology; Cancer
Assay Protocol
https://www.medchemexpress.com/levormeloxifene.html
Smiles
CC1([C@H]([C@@H](C2=CC=C(C=C2O1)OC)C3=CC=C(C=C3)OCCN4CCCC4)C5=CC=CC=C5)C
Molecular Formula
C30H35NO3
Molecular Weight
457.60
References & Citations
[1]Goldstein SR, et al., Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study. Am J Obstet Gynecol. 2002 Sep;187 (3) :521-7.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC743287-500 1x 500 µL
Nucleophosmin (Acute Myeloid Leukemia Marker) (NPM1/3287), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400778-500 1x 500 µL
Cytokeratin 17 (KRT17/778), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
AP18156PU-N 400 µL
Cyclophilin 40 (PPID) (N-term) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
